Use of compounds that regulate hdac6 tubulin deacetylase activity in the preparation of pharmaceutical compositions, method of identifying the aforementioned regulating compounds, said pharmaceutical compounds and applications thereof

摘要: The object of the present invention is use an HDAC6 protein tubulin deacetylase activity regulating, inhibiting or activating compound in developing new medicines for prophylaxis and treatment diseases mammals, preferably humans, occurring with immune system alterations, altered T lymphocyte activation; said regulating identification process, pharmaceutical compositions activation alterations. These may be used a method human being having immunological disease such as genetic acquired immunodeficiencies, vaccination processes, autoimmune inflammatory diseases.